Is olanzapine better than haloperidol in resistant schizophrenia? A double-blind study in partial responders

International Journal of Psychiatry in Clinical Practice

Volumn 6, Issue 2, 2002, Pages 107-111

  Altamura, A Carlo ^a   Velona I ^a   Curreli, R ^a   Mundo, E ^a   Bravi, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Negative symptoms; Olanzapine; Pharmacological treatment; Schizophrenia

Indexed keywords

BENZATROPINE MESILATE; BENZODIAZEPINE DERIVATIVE; BIPERIDEN; HALOPERIDOL; LORAZEPAM; OLANZAPINE;

ADULT; AKATHISIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; HUMAN; MULTICENTER STUDY; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA;

EID: 0036271577     PISSN: 13651501     EISSN: None     Source Type: Journal    
DOI: 10.1080/136515002753724117     Document Type: Article

References (24)

1. Clozapine for treatment-resistant schizophrenia: A double-blind comparison with chloropromazine
2. A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance
3. Treatment-resistant schizophrenia - The role of clozapine
4. Pharmacological treatment of schizophrenia
5. Patterns of response to neuroleptic treatment: Factors influencing the amelioration of individual symptoms in psychotic patients
6. Novel antipsychotics and the problem of clinical stabilization in schizophrenia: Are they "stabilizer" rather than typical compounds?
7. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
8. A comparison of the effects of quetiapine ('Seroquel') and haloperidol in schizophrenia patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment
9. Radioreceptor binding profile of the atypical antipsychotic olanzapine
10. Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial
11. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia
12. Olanzapine for patients with treatment-resistant schizophrenia: A naturalistic case-series outcome study
13. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia
14. Olanzapine compared with chloropromazine in treatment-resistant schizophrenia
15. Anchoring the BPRS: An aid to improved reliability
16. Negative symptoms in schizophrenia
17. A rating scale for extrapyramidal side effects
18. A rating scale for drug-induced akathisia
19. The role of serotonin in antipsychotic drug action
20. Serotonin-dopamine interaction and its relevance to schizophrenia
21. 2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
22. 2 receptor occupancy of olanzapine in schizophrenia: A PET investigation